Skip to content
value.today

Mitesco, Inc.

MITI
$35 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
$0 M
For year ending December-2025
Net income
$1 M
1250.0% margin
SEC filing
Employees
—

Mitesco, Inc. in brief

Mitesco, Inc. is a listed company in the Healthcare Information Services industry, based in Minnesota, USA. Its last known market value was $35 M (January 2022); there is no current figure. In the year to December 2025 it had sales of $0 M and a net profit of $0 M.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Mitesco, Inc.

This summary highlights selected information contained elsewhere in this filing and is qualified in its entirety by the more detailed information and financial statements included elsewhere in this report. It does not contain all the information that may be important to you and your investment decision. You should carefully read this entire filing, including the matters set forth under the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes. In this prospectus, unless context requires otherwise, references to “we,” “us,” “our,” or “the Company” refer to Mitesco, Inc. and its subsidiaries.

From the company's annual report filed with the US SEC: read the report

Mitesco, Inc. timeline

5 events, 2009–2021
  1. 2009
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2012
  4. ✎
    Renamed Trunity Holdings, Inc.
    Formerly Brain Tree International Inc.
  5. 2016
  6. ✎
    Renamed True Nature Holding, Inc.
    Formerly Trunity Holdings, Inc..
  7. 2020
  8. ✎
    Renamed Mitesco, Inc.
    Formerly True Nature Holding, Inc..
  9. 2021
  10. 💰
    Record revenue of $0 million
    FY2021, the highest of the 4 years on record.

Events of Mitesco, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

Not enough history yet.

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
1250.0%
Operating margin
-4700.0%
Return on equity
—
Liabilities / assets
18153.8%
Net debt
$-0M
Revenue growth
0.0%
R&D / revenue
200.0%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-1M—FY18Fiscal year ending Dec 2019: revenue $0M, net income $-4M$0MFY19Fiscal year ending Dec 2020: revenue —, net income $-3M—FY20Fiscal year ending Dec 2021: revenue $0M, net income $-8M$0MFY21Fiscal year ending Dec 2022: revenue —, net income $-23M—FY22Fiscal year ending Dec 2023: revenue —, net income $-13M—FY23Fiscal year ending Dec 2024: revenue $0M, net income $-3M$0MFY24Fiscal year ending Dec 2025: revenue $0M, net income $1M$0MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$0M0.0%$-2M$1M1250.0%
Dec 2024$0M—$-1M$-3M-6275.0%
Dec 2023——$-3M$-13M—
Dec 2022——$-4M$-23M—
Dec 2021$0M—$-6M$-8M-6600.0%
Dec 2020——$-3M$-3M—
Dec 2019$0M—$-1M$-4M—
Dec 2018——$-1M$-1M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-1M——$-0.14—
Dec 2024$-1M——$-0.42—
Dec 2023$-1M——$-2.91—
Dec 2022$-5M————
Dec 2021$-5M————
Dec 2020$-2M——$-0.03—
Dec 2019$-1M——$-0.09—
Dec 2018$-0M——$-0.06—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Sep 2024: revenue $0M, net income $2M$0MSep ’24Three months to Dec 2024 (from the annual report): revenue —, net income $-4M—Dec ’24Three months to Mar 2025: revenue $0M, net income $3M$0MMar ’25Three months to Jun 2025: revenue $0M, net income $-0M$0MJun ’25Three months to Sep 2025: revenue $0M, net income $-3M$0MSep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $0M—Dec ’25Three months to Mar 2026: revenue —, net income $-1M—Mar ’26Three months to Jun 2026: revenue $0M, net income $-1M$0MJun ’26

Latest quarter to Jun 2026: revenue $0M (0.0% on a year earlier), net income $-1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of Mitesco, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$0 M
Operating income
$-2 M
Net income
$1 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$0 M
Total liabilities
$24 M
Total equity
$-23 M

As of December-2025

Insider trading at Mitesco, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
19
since
Mitesco, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Brian ValaniaCEO and CFO, DirectorGrant or award+3.00 M$0.035$105 K3.42 MForm 4
filed Mack Rimmer Leath Jr.Chairman, DirectorGrant or award+3.00 M$0.040$120 K3.66 MForm 4
filed Brian ValaniaCEO and CFO, DirectorGrant or award+3.00 M$0.040$120 K3.42 MForm 4
filed Brian ValaniaCEO and CFO, DirectorGrant or award+221,078$0.080$18 K421,078Form 4
filed Brian ValaniaCEO and CFO, DirectorGrant or award+221,078$0.080$18 K421,078Form 4
filed Mack Rimmer Leath Jr.Chairman, DirectorGrant or award+242,154$0.080$19 K657,932Form 4
filed Mack Rimmer Leath Jr.Chairman, DirectorGrant or award+21,451$0.150$3 K415,778Form 4
filed Brian ValaniaCEO and CFO, DirectorGrant or award+83,334$0.035$3 K3.50 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Mitesco, Inc. scorecard#

Passes 3 of the 8 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 2
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-0.14 vs -0.42Diluted EPS -0.14 in fiscal 2025 against -0.42 the year before (report's currency).
    • ✓Net income higher than five years earlier$0 M$0 M in fiscal 2025 against -$3 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability1 of 2
    • ✓Profitable in the newest year$0 MNet income $0 M in fiscal 2025.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 3
    • ✗Short-term assets cover short-term liabilities0.0×Current ratio 0.01 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $0 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year289.8%Diluted shares up 289.8% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Mitesco, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Mitesco, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue394400r11603.5000
Cost of revenue——00r4560————
Gross profit——00r−3400————
Research and development820————————
Selling, general and administrative1,6921,1912,4554,331r6,0592,5341,4481,3167004,405
Operating expenses1,9171,2072,5874,331r6,0592,5341,4481,3167004,405
Operating income−1,878−1,164−2,587−4,331r−6,399−2,534−1,444−1,316−700−4,405
Interest expense and finance costs—1961,616r3,2119681,5161,6106754269r
Other non-operating income (expense)2,377−1,348−9,377−3,946r−1,524−327−2,441−99−54−476
Income before tax499−2,512−11,963−8,277r−7,923−2,861−3,885−1,415−754−4,881
Income tax0000000000
Income from continuing operations499−2,512−11,963−8,277——————
Income from discontinued operations—0−1,369−14,959——————
Net income including minority interests—————————−4,881
Net income attributable to shareholders499−2,512−13,332−23,236−7,923−2,861−3,885−1,415−754−4,881
Earnings per share, basic0.04-0.42-2.91r-5.29—-0.03-0.09-0.06-0.04-0.35
Earnings per share, diluted-0.14-0.42-2.91——-0.03-0.09-0.06-0.04-0.35
Shares, weighted average (basic)126.75.2r4.5———251814
Shares, weighted average (diluted)266.75.2——10545251814
Balance sheet
Cash and cash equivalents1013.42.836r1,164r65831.300
Receivables283000r440————
Inventory———0250————
Other current assets————————01.9
Current assets132382.81801,30765933.801.9
Property, plant and equipment——045r3,4766.37.90——
Right-of-use (leased) assets——084r3,8873100———
Other intangible assets01520———————
Total assets1321902.82,602r10,6557991013.801.9
Accounts payable3,8733,6777,0947,3533,9761,069649912r766589
Debt due within a year639548945r5,048r0r900———256
Current liabilities19,40218,44314,13517,802r5,5593,0292,4191,5351,3871,068
Lease liabilities (non-current)0003,937r3,9733120———
Total liabilities23,60526,60614,13521,739r9,5323,3412,4191,6581,3871,068
Retained earnings−63,357−63,855−62,047−48,714r−25,478−14,437−11,577−7,691−6,276−5,522
Shareholders' equity−23,473−26,416−14,132−19,137r1,123−2,542−2,318−1,654−1,387−1,066
Total liabilities and equity1321902.82,602r10,6557991013.801.9
Shares outstanding159.85.64.64.3r15581321917
Cash-flow statement
Share-based compensation8257029054511,0405682344562623,378
Cash from operating activities−702−514−760−5,174−4,996−1,521−784−247−47−270
Acquisitions, net of cash acquired0−5.00———−7.90——
Cash from investing activities0−5.00−1,749−1,9280−7.9000
Debt issued20054804,3590—————
Debt repaid——−12———————
Shares issued———01,6680———60r
Cash from financing activities7995207275,7948,0241,50287424847241
Change in cash———————1.30−28
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at Mitesco, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Change in control 3 · Directors and officers 10 · Material agreement 16 · Unregistered share sale 21 · Bylaws or fiscal year changed 1

Mitesco, Inc.: events reported to the SEC
FiledWhat happenedFiling
Directors and officersUnregistered share saleBylaws or fiscal year changed8-K
Directors and officersUnregistered share sale8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Directors and officersUnregistered share sale8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Directors and officersMaterial agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Directors and officers8-K
Material agreementUnregistered share sale8-K
Unregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Material agreementUnregistered share sale8-K
Unregistered share sale8-K/A
Unregistered share sale8-K
Material agreement8-K
Change in controlDirectors and officersMaterial agreementUnregistered share sale8-K
Change in controlMaterial agreementUnregistered share sale8-K/A
Change in controlMaterial agreementUnregistered share sale8-K
Directors and officers8-K
Material agreementUnregistered share sale8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 6, 2026

Acquisitions and funding#

1 private funding rounds before listing

Private share sales · funding history

Private share sales of Mitesco, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2024$14 MPrivate placement after listing$10 to $50 million6equitySEC
Oct 2021$3 MPrivate placement after listing$2 to $10 million9equity, optionsSEC
Mar 2021$2 MPrivate placement after listingUnder $2 million45equitySEC
Mar 2021$3 MPrivate placement after listing$2 to $10 million4equity, optionsSEC
May 2013$4 MNo. 1$2 to $10 million35equity, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Layoffs at Mitesco, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
0
2015–2016
Latest
—
2016-09-20
Mitesco, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2016············—
2015············—
Mitesco, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
Not statedRestructuring planSEC 8-KCompany-wide planFiling
Not statedRestructuring planSEC 8-KCompany-wide planFiling

Source: State WARN notices and SEC 8-K item 2.05

How Mitesco, Inc. compares in Healthcare Information Services

  • Revenue$0 M · higher than 0% of 70
  • Revenue growth0.0% · higher than 19% of 38

Peer comparison · Healthcare Information Services

CompanyMarket capP/ENet marginRev. growth
Mitesco, Inc.🇺🇸$35 M——0.0%
Veeva Systems Inc.🇺🇸$50.2 B49.5×29.4%+16.3%
Pro Medicus Limited🇦🇺$14.4 B81.3×——
10x Genomics, Inc.🇺🇸$9.4 B—-10.8%+5.3%
HealthEquity, Inc.🇺🇸$8.3 B35.3×17.4%+9.5%
M3, Inc.🇯🇵$7.1 B21.5×14.0%—
Doximity, Inc.🇺🇸$5.5 B39.5×21.1%+13.1%
Privia Health Group, Inc.🇺🇸$2.8 B80.9×1.4%+22.3%
Winning Health Technology Group Co., Ltd.🇨🇳$2.3 B41.3×13.8%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Mitesco, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Mitesco, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Mitesco, Inc.? Suggest a correction